Healthcare Costs of Treating Privately Insured Patients with Acute Myeloid Leukemia in the United States from 2004 to 2014: A Generalized Additive Modeling Approach

被引:0
作者
Lih-Wen Mau
Jaime M. Preussler
Linda J. Burns
Susan Leppke
Navneet S. Majhail
Christa L. Meyer
Tatenda Mupfudze
Wael Saber
Patricia Steinert
David J. Vanness
机构
[1] National Marrow Donor Program/Be The Match,
[2] Center for International Blood and Marrow Transplant Research,undefined
[3] Blood & Marrow Transplant Program,undefined
[4] Cleveland Clinic,undefined
[5] Center for International Blood and Marrow Transplant Research,undefined
[6] Apriori Bayesian Consulting,undefined
[7] LLC,undefined
来源
PharmacoEconomics | 2020年 / 38卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:515 / 526
页数:11
相关论文
共 180 条
[1]  
O’Donnell MR(2017)Acute myeloid leukemia, version 3.2017, NCCN clinical practice guidelines in oncology J Natl Compr Canc Netw 15 926-957
[2]  
Tallman MS(2012)Costs and cost-effectiveness of hematopoietic cell transplantation Biol Blood Marrow Transplant 18 1620-1628
[3]  
Abboud CN(2013)Costs of autologous and allogeneic hematopoietic cell transplantation in the United States: a study using a large national private claims database Bone Marrow Transplant 48 294-573
[4]  
Altman JK(2009)Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications Biol Blood Marrow Transplant 15 564-1551
[5]  
Appelbaum FR(2012)Economics of hematopoietic cell transplantation Blood 120 1545-141
[6]  
Arber DA(2010)Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review Health Technol Assess 14 1-2323
[7]  
Preussler JM(2016)The superiority of allogeneic hematopoietic stem cell transplantation over chemotherapy alone in the treatment of acute myeloid leukemia patients with mixed lineage leukemia (MLL) rearrangements Med Sci Monit 22 2315-250
[8]  
Denzen EM(2013)The costs of initial treatment for patients with acute myeloid leukemia in the Netherlands Leuk Res 37 245-29
[9]  
Majhail NS(2016)Medical costs of treatment and survival of patients with acute myeloid leukemia in Belgium Leuk Res 46 26-1028
[10]  
Majhail NS(2017)Healthcare costs and utilization for patients age 50–64 years with acute myeloid leukemia treated with chemotherapy or with chemotherapy and allogeneic hematopoietic cell transplantation Biol Blood Marrow Transplant 23 1021-1080